synergy nash tirzepatide Will the GLP-1 giants kill the smid-caps? Tough week for some smid-cap NASH stocks 2/6/24 $LLY announced 📢 • positive Ph2 MASH (AKA NASH) data ⇨ MASH resolution (74%) of Post-hoc analysis of SYNERGY-NASH trial

With significant weight loss there is worries about negative impacts on muscle quantity, health and function, particularly in more vulnerable patients

When you know why you are drawing a specific volume, you can troubleshoot problems, adjust protocols, and make informed decisions about your research approach

Phentermine is a sympathomimetic designed for short-term use, while semaglutide is for chronic usecombining them creates an unpredictable long-term safety profile that lacks clinical evidence

Treatment of chronic postinfectious fatigue: Randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo

The answer depends on what is included in the stack

Resistance training amplifies muscle preservation effects